No price history available.
Key financial summary
Financials in NZD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | NZDm | 1,302 | 1,367 | 1,397 | 1,321 | 1,637 | 1,827 | N/A | N/A |
| Operating profit | NZDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | NZDm | 75 | -28 | 39 | -4 | -182 | -40 | N/A | N/A |
| EPS reported | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | NZDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | NZDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | NZDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in NZD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Synlait Milk Limited, alongside its associated entities, creates and markets a diverse portfolio of dairy products, serving international territories including China, the wider Asian region, the Middle East, Africa, Australia, and its home base of New Zealand. The company's operations encompass the processing, packaging, and promotion of various milk-based goods, such as different types of cheese, butter, and powdered milk. Its comprehensive product line features fresh liquid milk, an array of powdered milk derivatives, specialized dietary formulas for infants and adults, and essential ingredients like skim milk powder and anhydrous milk fat. Additionally, it supplies advanced nutritional components, specifically lactoferrin. The firm was established in 2005 and is headquartered in Rakaia, New Zealand.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Synlait Milk Limited (SML.NZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Synlait Milk Limited, alongside its associated entities, creates and markets a diverse portfolio of dairy products, serving international territories including China, the wider Asian region, the Middle East, Africa, Australia, and its home base of New Zealand. The company's operations encompass the processing, packaging, and promotion of various milk-based goods, such as different types of cheese, butter, and powdered milk. Its comprehensive product line features fresh liquid milk, an array of powdered milk derivatives, specialized dietary formulas for infants and adults, and essential ingredients like skim milk powder and anhydrous milk fat. Additionally, it supplies advanced nutritional components, specifically lactoferrin. The firm was established in 2005 and is headquartered in Rakaia, New Zealand.